0001209191-17-054484.txt : 20171002 0001209191-17-054484.hdr.sgml : 20171002 20171002140113 ACCESSION NUMBER: 0001209191-17-054484 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170928 FILED AS OF DATE: 20171002 DATE AS OF CHANGE: 20171002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RINGO WILLIAM R CENTRAL INDEX KEY: 0001238325 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36070 FILM NUMBER: 171114008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC CENTRAL INDEX KEY: 0001175505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260038620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-365-5600 MAIL ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-09-28 0 0001175505 FIVE PRIME THERAPEUTICS INC FPRX 0001238325 RINGO WILLIAM R TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2017-09-28 4 M 0 2000 11.65 A 2000 D Common Stock 2017-09-28 4 S 0 2000 38.00 D 0 D Stock Option (right to buy) 11.65 2017-09-28 4 M 0 2000 0.00 D 2024-09-30 Common Stock 2000 19000 D The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on April 15, 2016. The shares underlying this option vest at a rate of one-third per year on each anniversary of October 1, 2014. /s/ Francis Sarena, Attorney-in-Fact 2017-10-02